Int J Mol Med 2013
COA / Lab results Evidence: Clinical trial Pros Triple GLP-1 / GIP / glucagon agonism in one peptide raises energy expenditure, not appetite alone Largest weight reduction reported for an incretin-class compound (~24% at 12 mg, 48-wk phase 2) Reductions in HbA1c, visceral fat and liver-fat content across trials Once-weekly subcutaneous dosing (albumin-bound half-life) Cons GI effects require gradual multi-week dose titration Newest of the GLP-1 class phase 3 (TRIUMPH) topline only
Greek Yogurt With Probiotics and Fiber Greek yogurt is another breakfast staple that works especially well for GLP-1 users
J Berry Res
Ipamorelin delivers faster results focused on fat loss, muscle gain, and recovery through a distinct, highly selective pathway
As a regenerative medicine specialist deeply dedicated to evidence-based musculoskeletal treatments , including platelet-rich plasma (PRP) therapy , stem cell therapies , and advanced interventional musculoskeletal procedures , I feel it is essential to address these questions with scientific clarity